Capital Markets Day 2017

Novo Nordisk Capital Markets Day on 21 November 2017

On 21 November 2017, Novo Nordisk will host a Capital Markets Day for institutional investors and financial analysts at the R&D campus in Måløv, Denmark. The day will be organised around plenum presentations and Q&A.

The day will commence at 09.00 and finish at 16.30. All sessions will be webcasted live and the link to access the webcast will be made available here as we get closer to the Capital Markets Day.

Agenda and presentations

- Welcome and strategy update (link to presentation)

- R&D update (link to presentation)

- Driving insulin growth (link to presentation)

- Winning with GLP-1 (link to presentation)

- Strengthen leadership in obesity (link to presentation)

- International Operations update (link to presentation)

- US update (link to presentation

- Biopharm dynamics - break-out session (link to presentation)

- Oral semaglutide and production expansion - break-out session (link to presentation)

- Region China and Region AAMEO - break-out session (link to presentation)

- Financial update and closing remarks (link to presentation)

- Day 2 - Production facilities Kalundborg (link to presentation)


Webcast, please use the following link to access to the webcast 


If you have any questions, you are welcome to contact Novo Nordisk Investor Relations: 

+45 3075 9085              Peter Hugreffe Ankersen
+45 3079 8519              Hanna Ögren
+45 3079 4461              Anders Mikkelsen
+45 3079 3009              Christina Kjær
+1 609 235 8567           Kasper Veje (US)